Xeris Biopharma Holdings Inc reports results for the quarter ended in January - Earnings Summary

Xeris Biopharma Holdings

09/05/2024 19:43

* Xeris Biopharma Holdings Inc  XERS.OQ  reported a
quarterly
adjusted loss of 14 cents​​ per share for the quarter ended in
January, lower than the same quarter last year, when the company
reported EPS of -12 cents.  The mean expectation of six analysts
for the quarter was for a loss of 12 cents per share. Wall
Street expected results to range from -14 cents to -11 cents per
share.
    * Revenue rose 22.4% to $40.64 million from a year ago;
analysts
expected $41.81 million. 
    * Xeris Biopharma Holdings Inc's reported EPS for the
quarter was
a loss of 14 cents​.
    * The company reported a quarterly loss of $18.98 million.
    * Xeris Biopharma Holdings Inc shares had fallen by 16.3%
this
quarter and lost 21.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 34.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is  "buy."

Wall Street's median 12-month price target for Xeris Biopharma
Holdings Inc is $4.75 
This summary was machine generated from LSEG data May 9 at 06:42
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.12          -0.14          Missed
 Dec. 31 2023      -0.10          -0.10          Met
 Sep. 30 2023      -0.12          -0.09          Beat
 Jun. 30 2023      -0.13          -0.14          Missed